| Nongenetic Determinants of Risk for Early-Onset Colorectal Cancer | JNCI Cancer Spectrum | 33 days | save |  |  |  |  |
| Prevention of Early-Onset Colorectal Cancer: Not One Size Fits All | JNCI Cancer Spectrum | 33 days | save | | | | |
| Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance) | JNCI Cancer Spectrum | 33 days | save | | | | |
| Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk Models | JNCI Cancer Spectrum | 33 days | save | | | | |
| Relation of Quantitative Histologic and Radiologic Breast Tissue Composition Metrics With Invasive Breast Cancer Risk | JNCI Cancer Spectrum | 33 days | save | | | | |
| Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer | JNCI Cancer Spectrum | 33 days | save | | | | |
| Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer | JNCI Cancer Spectrum | 55 days | save | | | | |
| Human Papillomavirus Vaccination After COVID-19 | JNCI Cancer Spectrum | 55 days | save | | | | |
| DeImplementing Ineffective and Low-Value Clinical Practices: Research and Practice Opportunities in Community Oncology Settings | JNCI Cancer Spectrum | 55 days | save | | | | |
| A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus | JNCI Cancer Spectrum | 55 days | save | | | | |
| Disparities in Cardiovascular Disease Risk Among Hispanic Breast Cancer Survivors in a Population-Based Cohort | JNCI Cancer Spectrum | 55 days | save | | | | |
| Adverse Events and Perception of Benefit From Duloxetine for Treating Aromatase Inhibitor-Associated Arthralgias | JNCI Cancer Spectrum | 55 days | save | | | | |
| Association of Daily Alcohol Intake, Volumetric Breast Density, and Breast Cancer Risk | JNCI Cancer Spectrum | 55 days | save | | | | |
| Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States | JNCI Cancer Spectrum | 55 days | save | | | | |
| Protective Effects of APOEε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study | JNCI Cancer Spectrum | 55 days | save | | | | |
| Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations | JNCI Cancer Spectrum | 55 days | save | | | | |
| Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study | JNCI Cancer Spectrum | 55 days | save | | | | |
| Associations Between Amplification (1q) and Prior Cancer in a Real-World De Novo Myeloma Cohort | JNCI Cancer Spectrum | 165 days | save | | | | |
| A Call to Action:“Low-Dose Radiation May Help Cure COVID-19…” [Taps Mic] “…Is This Thing On?” | JNCI Cancer Spectrum | 165 days | save | | | | |
| Low-Dose Radiation Therapy for COVID-19: Promises and Pitfalls | JNCI Cancer Spectrum | 165 days | save | | | | |
| Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study | JNCI Cancer Spectrum | 165 days | save | | | | |
| Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors | JNCI Cancer Spectrum | 165 days | save | | | | |
| Presentation, Management, and Outcomes Across the Rural-Urban Continuum for Hepatocellular Carcinoma | JNCI Cancer Spectrum | 165 days | save | | | | |
| Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study | JNCI Cancer Spectrum | 165 days | save | | | | |
| Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer | JNCI Cancer Spectrum | 165 days | save | | | | |
| Quantitative Mammographic Density Measurements and Molecular Subtypes in Chinese Women With Breast Cancer | JNCI Cancer Spectrum | 165 days | save | | | | |
| Concordance of Immunohistochemistry-Based and Gene Expression-Based Subtyping in Breast Cancer | JNCI Cancer Spectrum | 165 days | save | | | | |
| Risk Factors and Incidence of Colorectal Cancer According to Major Molecular Subtypes | JNCI Cancer Spectrum | 165 days | save | | | | |
| Breast Cancer Mortality Hot Spots Among Black Women With de Novo Metastatic Breast Cancer | JNCI Cancer Spectrum | 165 days | save | | | | |
| Long-Term Prognostication for 20 114 Women With Small and Node-Negative Breast Cancer (T1abN0) | JNCI Cancer Spectrum | 165 days | save | | | | |
| Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological Features | JNCI Cancer Spectrum | 165 days | save | | | | |
| Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes | JNCI Cancer Spectrum | 165 days | save | | | | |
| IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405 | JNCI Cancer Spectrum | 165 days | save | | | | |
| Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16INK4a | JNCI Cancer Spectrum | 174 days | save | | | | |
| Protein Intake by Source and Breast Cancer Incidence and Mortality: The Women’s Health Initiative | JNCI Cancer Spectrum | 175 days | save | | | | |
| Proximity to Oil Refineries and Risk of Cancer: A Population-Based Analysis | JNCI Cancer Spectrum | 207 days | save | | | | |
| When Should Oncologists Use the Words Hope and Cure? | JNCI Cancer Spectrum | 207 days | save | | | | |
| Oncologists’ Reluctance to Use the Terms Hope and Cure: A Bibliometric Analysis of Articles From Two High-Impact Oncology Journals | JNCI Cancer Spectrum | 207 days | save | | | | |
| Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled Trial | JNCI Cancer Spectrum | 207 days | save | | | | |
| Changes in Black-White Difference in Lung Cancer Incidence among Young Adults | JNCI Cancer Spectrum | 305 days | save | | | | |
| | 
report | |
| |
